Abstract
Severe cortex lesions in the hippocampal, parahippocampal and medial temporal lobe (MTL) of Alzheimers disease subjects have been observed by functional magnetic resonance imaging (fMRI) during memory task performance. To date, fMRI technology has not been used to investigate the frontal lobe function of Alzheimers subjects. This study determines if fMRI can be used to assess altered prefrontal cortex activity during Stroop task performance in subjects wih mild cognitive impairment (MCI) and Alzheimers disease (AD). Functional magnetic resonance imaging (fMRI) was performed on 9 healthy elderly controls, 9 subjects with mild cognitive impairment and 10 patients with Alzheimers disease, to examine the prefrontal changes in fMRI activation in relation to the Stroop color-word paradigm. In comparison with controls, MCI subjects showed distinctly increased cortex activity including: the dorsal anterior cingulate, bilateral middle and inferior frontal gyri, bilateral inferior parietal lobule, and the bilateral insular. In contrast, AD subjects exhibited decreased fMRI responses in the regions of the prefrontal cortex listed above. These results imply two different neurophysiological characteristics of MCI and AD. In MCI, a compensatory activity of the prefrontal cortex is observed, whereas in AD a dysfunction of the prefrontal cortex is indicated.
Keywords: Alzheimer's disease, Mild cognitive impairment, Stroop task, fMri
Current Alzheimer Research
Title: An fMRI Stroop Task Study of Prefrontal Cortical Function in Normal Aging, Mild Cognitive Impairment, and Alzheimers Disease
Volume: 6 Issue: 6
Author(s): Chuanming Li, Jian Zheng, Jian Wang, Li Gui and Chuan Li
Affiliation:
Keywords: Alzheimer's disease, Mild cognitive impairment, Stroop task, fMri
Abstract: Severe cortex lesions in the hippocampal, parahippocampal and medial temporal lobe (MTL) of Alzheimers disease subjects have been observed by functional magnetic resonance imaging (fMRI) during memory task performance. To date, fMRI technology has not been used to investigate the frontal lobe function of Alzheimers subjects. This study determines if fMRI can be used to assess altered prefrontal cortex activity during Stroop task performance in subjects wih mild cognitive impairment (MCI) and Alzheimers disease (AD). Functional magnetic resonance imaging (fMRI) was performed on 9 healthy elderly controls, 9 subjects with mild cognitive impairment and 10 patients with Alzheimers disease, to examine the prefrontal changes in fMRI activation in relation to the Stroop color-word paradigm. In comparison with controls, MCI subjects showed distinctly increased cortex activity including: the dorsal anterior cingulate, bilateral middle and inferior frontal gyri, bilateral inferior parietal lobule, and the bilateral insular. In contrast, AD subjects exhibited decreased fMRI responses in the regions of the prefrontal cortex listed above. These results imply two different neurophysiological characteristics of MCI and AD. In MCI, a compensatory activity of the prefrontal cortex is observed, whereas in AD a dysfunction of the prefrontal cortex is indicated.
Export Options
About this article
Cite this article as:
Li Chuanming, Zheng Jian, Wang Jian, Gui Li and Li Chuan, An fMRI Stroop Task Study of Prefrontal Cortical Function in Normal Aging, Mild Cognitive Impairment, and Alzheimers Disease, Current Alzheimer Research 2009; 6 (6) . https://dx.doi.org/10.2174/156720509790147142
DOI https://dx.doi.org/10.2174/156720509790147142 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances of Liquid Chromatographic Determination of Fumonisins; Potential Mycotoxins for Humans
Current Pharmaceutical Analysis Bronchiolitis Care in the Hospital
Reviews on Recent Clinical Trials NAD+ Metabolism and NAD+-Dependent Enzymes: Promising Therapeutic Targets for Neurological Diseases
Current Drug Targets Oxidative Stress and NAD+ in Ischemic Brain Injury: Current Advances and Future Perspectives
Current Medicinal Chemistry A Comprehensive Review on Hydrogels
Current Drug Delivery Neurogenic plasticity of mesenchymal stem cell, an alluring cellular replacement for traumatic brain injury
Current Stem Cell Research & Therapy ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Current Neuropharmacology Adamantane – A Lead Structure for Drugs in Clinical Practice
Current Medicinal Chemistry CD44 and its Role in Inflammation and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application
Current Vascular Pharmacology Patent Selections:
Recent Patents on Biomarkers Role of PPAR in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Brain Oxidative Markers in Stress: Possible New Drug Targets Against Neuroinflammation
Current Neuropharmacology Potential Application of Dietary Polyphenols from Red Wine to Attaining Healthy Ageing
Current Topics in Medicinal Chemistry The Potentials of Selected Therapeutic Targets for Inflammation: A Snapshot
Recent Patents on Inflammation & Allergy Drug Discovery Free Radical Scavenger Edaravone Administration Protects against Tissue Plasminogen Activator Induced Oxidative Stress and Blood Brain Barrier Damage
Current Neurovascular Research G-Lymphatic, Vascular and Immune Pathways for Aβ Clearance Cascade and Therapeutic Targets For Alzheimer’s Disease
Combinatorial Chemistry & High Throughput Screening Treating Cancer and No-Cancer Pain in Older and Oldest Old Patients
Current Pharmaceutical Design Combat Military Personnel and Selective Risk Factors for the Development of Dementias - A Review
Current Psychiatry Research and Reviews Conference Report: 7th Clinical Trials on Alzheimer’s Disease Annual Conference, Philadelphia, PA, USA Nov 20-22, 2014
CNS & Neurological Disorders - Drug Targets